About Parul Singh
Parul Singh is an investment partner at 645 Ventures in San Francisco, where she invests in AI software, developer tools and infrastructure. She sits on the board of Cofertility, which she backed as a partner at Initialized Capital. Initialized co-led Cofertility's seed round in 2022.
She became a partner at Initialized Capital in 2021, after working on the investing team at Founder Collective. She is also a director of Neurolytic Healthcare (Mable). Before venture capital she spent about a decade as an engineer and product manager, including at The New York Times, Inc. Magazine and Fast Company.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Parul Singh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Parul Singh works with at each company, as listed on that company's latest Form D.
Parul Singh in the News
Sources
- SECCofertility, Inc. Form D, filed Oct 15, 2026
- Firm siteInitialized Capital blog: welcome post for Parul Singh (2021-07-15)
- Firm siteInitialized Capital blog: post by Parul Singh on Mable Health (2022-07-27)
- SEC filingNeurolytic Healthcare, Inc. Form D filed 2021-12-29
- Government siteUK Companies House: Neurolytic Healthcare Ltd, officers
- Government siteUK Companies House: Neurolytic Healthcare Ltd, overview (status dissolved)
- Company siteCofertility Series A announcement, April 10, 2025 (names Initialized Capital among its investors)